We Can Help.

Contact us today for a complimentary consultation with a qualified attorney near you.

 
Subscribe To Our Syndicated News    |  

Reglan 
Reglan® Injuries
Tardive Dyskinesia Designed to treat gastroesophageal reflux, Reglan® has been linked to the development of tardive dyskinesia, a very serious and often irreversible movement disorder. In fact, in February 2009, the U.S. Food and Drug Administration (FDA) required the manufacturers to include a Black Box warning on the prescribing information to highlight the potential risk of tardive dyskinesia in Reglan® users. Learn more about Reglan® and Tardive Dyskinesia / Contact a Reglan® Attorney / Reglan® Side Effects

Welcome To A Drug Recall

At ADrugRecall.com, we’re committed to providing our readers with the latest news and information about defective and harmful drugs. We cover breaking news stories, offer tips for consumer safety, provide information on alternative therapies, and more. Our goal is to empower you—our reader—by giving you the knowledge you need when you need it most. If you have a legal issue involving a defective drug, we can direct you to a respected and experienced attorney near you who can inform you of your legal rights and options. We hope you find our site helpful and easy-to-use. Please visit again soon! Read more about AdrugRecall.com.


Featured Article

Genentech, the manufacturer of Raptiva® (a drug designed to treat Psoriasis), announced a voluntary recall of the medication April 8, 2009. According to a statement issued by the U.S. Food and Drug Administration (FDA), Genentech decided to issue a Raptiva® recall because of the risk to users of developing a fatal brain infection, progressive multifocal leukoencephalopathy (PML). The recall strongly advises all Raptiva® users to stop treatment and all prescribers to work with patients on alternative treatment plans... More Raptiva® News

News Stories

Yaz® and Yasmin® Lawsuits Are on the Rise

Legal professionals are reporting that injuries caused by the fourth generation birth control pills, Yaz® and Yasmin® have given birth to a new mass tort.

Learn More...

FDA Announces Botox® Black Box Warning

The U.S. Food and Drug Administration (FDA) announced a Botox® black box warning, Aug. 3, 2009.

Learn More...

 

More Defective Drug News....

 
Alternative Therapy

Yaz®, a popular form of birth control, has been in the legal spotlight recently. The contraceptive gained popularity at the onset of its attractive marketing campaign designed by manufacturer, Bayer Healthcare Pharmaceuticals. However, in early 2009, the FDA blew the lid off the campaign, revealing that some of the information about Yaz® Birth Control was incorrect. Demanding a correction, the FDA required Bayer to create a new marketing campaign that, not only corrected the false claims, but also highlighted the serious, potentially fatal Yaz® side effects, including heart attack, stroke and pulmonary embolism.